Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs aimed at increasing the horizons of cytokine-based immunotherapy, specifically for cancers where treatment method alternatives remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Take a look https://financefeeds.com/unlock-new-trading-opportunities-with-ebcs-us-stock-cfds/